title: Cryptococcosis: a model for the understanding of infectious diseases.
abstract: The increase in immunosuppressed patient populations has correlated with a rise in clinical fungal infections, including cryptococcosis. Patient outcome following Cryptococcus infection is linked to initial fungal burden in cerebrospinal fluid (CSF) and fungal clearance following treatment; however, the role of the pathogen in disease prognosis is poorly defined. In this issue of the JCI, Sabiiti and colleagues have directly correlated phenotypic traits of Cryptococcus neoformans with clinical outcome of infected patients. A better understanding of both the host and pathogen contributions to disease etiology will provide more options for targeted treatment strategies.
authors.forename: John R
authors.initials: JR
authors.lastname: Perfect
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000378:metabolism*; D000818:Animals; D003455:Cryptococcus neoformans / Q000378:metabolism*; D005260:Female; D006801:Humans; D008264:Macrophages / Q000378:metabolism*; D008297:Male; D016919:Meningitis, Cryptococcal / Q000378:metabolism*; D010587:Phagocytosis
references.citation: J Infect Dis. 2014 Jan 1;209(1):74-82
references.pmid: 23945372
references.citation: PLoS One. 2012;7(8):e43582
references.pmid: 22937064
references.citation: Clin Infect Dis. 2014 Mar;58(5):736-45
references.pmid: 24319084
references.citation: Clin Infect Dis. 2010 Feb 1;50(3):291-322
references.pmid: 20047480
references.citation: PLoS Pathog. 2010 Apr 22;6(4):e1000850
references.pmid: 20421942
references.citation: Antimicrob Agents Chemother. 2013 Jun;57(6):2485-95
references.pmid: 23478968
references.citation: J Immunol. 2013 Apr 15;190(8):3959-66
references.pmid: 23509356
references.citation: PLoS Genet. 2014 Apr 17;10(4):e1004261
references.pmid: 24743168
references.citation: mBio. 2014 Feb 04;5(1):e01087-13
references.pmid: 24496797
references.citation: Clin Vaccine Immunol. 2013 Jan;20(1):52-5
references.pmid: 23114703
references.citation: Clin Infect Dis. 2009 Sep 1;49(5):702-9
references.pmid: 19613840
references.citation: AIDS. 2009 Feb 20;23(4):525-30
references.pmid: 19182676
references.citation: AIDS. 2012 Jun 1;26(9):1105-13
references.pmid: 22421244
references.citation: PLoS Med. 2010 Dec 21;7(12):e1000384
references.pmid: 21253011
references.citation: Lancet Infect Dis. 2007 Jun;7(6):395-401
references.pmid: 17521592
references.citation: J Clin Invest. 2014 May;124(5):2000-8
references.pmid: 24743149
references.citation: BMC Genomics. 2011 Oct 27;12:526
references.pmid: 22032296
references.citation: G3 (Bethesda). 2013 Apr 9;3(4):675-686
references.pmid: 23550133
references.citation: N Engl J Med. 2013 Apr 4;368(14):1291-1302
references.pmid: 23550668
references.citation: mBio. 2013 Aug 27;4(5):e00573-13
references.pmid: 23982074